Edition:
United States

ICON PLC (ICLR.OQ)

ICLR.OQ on NASDAQ Stock Exchange Global Select Market

143.68USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$143.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,791
52-wk High
$149.68
52-wk Low
$101.22

Chart for

About

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the... (more)

Overall

Beta: 0.32
Market Cap(Mil.): $7,805.83
Shares Outstanding(Mil.): 54.33
Dividend: --
Yield (%): --

Financials

  ICLR.OQ Industry Sector
P/E (TTM): 25.98 99.36 30.45
EPS (TTM): 5.53 -- --
ROI: -- 2.89 12.63
ROE: -- 1.65 14.82

BRIEF-Icon To Cut Administrative Costs And Raise Regulatory Compliance

* ICON LAUNCHES FIRECREST FINANCIAL DISCLOSURE TO REDUCE ADMINISTRATIVE COSTS AND INCREASE REGULATORY COMPLIANCE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 21 2018

BRIEF-ICON Plc Reports Q1 Earnings Per Share Of $1.42

* EXCLUDING IMPACT OF ASC 606, CLOSING BACKLOG OF $5,053 MILLION AT QUARTER END , AN INCREASE OF 17.2% YEAR ON YEAR

May 02 2018

BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials

* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTEL® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS

Apr 17 2018

Earnings vs. Estimates